# XYL earnings call intelligence

LOPJLB CallCard / temporal rollup · freemium · [stock page](https://www.lopjlb.com/stock/XYL) · [Earnings tab](https://www.lopjlb.com/stock/XYL?tab=earnings)

Updated: 2026-07-28T04:32:53

Quarters analyzed: 8

## Cross-quarter narrative

Across six quarters Xylem moved from a strong growth burst in mid‑2024—9% organic revenue growth, 170bps EBITDA margin expansion and an upgraded FY guide—to a phase of record profitability tempered by emerging headwinds. Margin expansion accelerated from 21.2% in Q3 2024 to over 23% by Q3 2025, driven by productivity, pricing and the 80/20 simplification program. Demand remained resilient in core utility and industrial markets, with book‑to‑bill consistently above 1, yet visibility eroded as tariff uncertainty, China’s 30% YoY order decline and project‑timing delays in MCS and WSS surfaced. The company doubled down on capital discipline: active M&A (Idrica, Vacom, Envirex, German instrument firm), divestitures, and a $1.5 bn share‑repurchase plan, while raising dividends. 80/20 actions delivered margin uplift but also created a 2% top‑line headwind in 2025‑26. Macro volatility—from elections to Middle‑East conflict—recurred, adding to pricing pressure and supply‑chain risks. Despite these challenges, Xylem’s backlog stayed robust (~$5 bn) and transformation milestones (Evoqua integration, operating‑model phases) stayed on track, positioning the firm for modest organic growth (2‑4%) and continued margin expansion in 2026.

## Latest CallCard · Q1

Xylem delivered solid Q1 2026 results with resilient demand, strong book-to-bill, $850M WSS outsourced water contract, maintained organic guidance, increased dividend, $581M buyback, and a $219M acquisition.

**Guidance:** maintained — Full-year organic revenue growth 2-4% unchanged; reported revenue raised to $9.2-9.3B due to divestiture delay; EBITDA margin 22.9-23.3%; EPS $5.35-5.60 unchanged.

**Tone:** mgmt 0.4 · Q&A pressure 0.35 · divergence 0.05

Management emphasized resilience, solid performance, confidence in business, and balanced capital allocation despite dynamic environment.

### Demand visibility

Solid demand with backlog up to $4.7B, book-to-bill >1; U.S. utility orders up double digits; China down 30% but bottoming; MCS orders up 15%; WSS booked record $850M contract.

U.S. utility demand resilient per CEO meetings with 15 utility CEOs; MCS driven by smart metering in Southeast U.S.; Water Infrastructure supported by transport in U.S. and India; Applied Water lifted by data center wins; WSS capital project timing caused Q1 decline but April brought largest-ever order.

### Margins / costs

Q1 EBITDA margin 20.6% (+20 bps) driven by productivity and price offsetting inflation, mix, volume; full-year margin expansion 70-110 bps targeted; MCS to exit >25% post-divestiture; Applied Water to improve above 20%.

Price-cost positive across portfolio; teams proactive on pricing and sourcing; fuel surcharges implemented; MCS margin expansion delayed to H2 due to energy mix; Water Infrastructure margin up 120 bps; Applied Water margin below expectations due to mix but confident in sequential improvement.

### Capital allocation

Dividend increased ~8%; $1.5B share repurchase authorized, $581M executed in Q1; $219M acquisition of German water quality instruments firm; targeting $1B annual M&A; leverage managed at 0.5-1.0x net debt/EBITDA.

Continued buybacks in April, reassessing monthly; balancing leverage with stock dislocation; M&A pipeline strong across segments with segment presidents owning process; acquisition adds high-margin optical sensing and revenue synergies.

### Milestones

- **WSS largest-ever outsourced water contract** [delivered]: $850M, 20-year service contract, 75% service/25% capital, 10% revenue recognized in 2026, capital build 2027, service start 2028
- **International metering divestiture** [delayed]: Regulatory approval timing pushes close to end of Q2 2026
- **German water quality instruments acquisition** [new]: $219M signed agreement, expands high-margin optical sensing and process applications
- **Self-improvement/transformation initiatives** [on_track]: Simplifying structure and processes, strengthening resilience, enabling growth engine
- **80/20 walk-away actions** [on_track]: Peak impact in 2026, weighted to first 2-3 quarters, primarily in China and Western Europe treatment business
- **M&A pipeline targeting $1B annual deployment** [on_track]: Strong pipeline across segments, bottom-up process led by segment presidents
- **Leadership changes: Chief Growth & Commercial Officer, Chief Innovation & Product Officer** [delivered]: Snehal Desai and Sivan Zamir appointed to accelerate growth and innovation
- **2025 sustainability goals achieved** [delivered]: Water reuse, pollution prevention, stewardship goals met; 2030 agenda launched

### Fears / risks

- **Macro volatility**: Middle East conflict, tariff changes, inflationary pressures, currency and interest rate fluctuations
- **China demand**: 30% YoY decline, mix of market weakness, competitor actions, and intentional walk-away; uncertainty on recovery pace
- **Tariff and inflation impact**: Rising fuel costs, potential tariff escalation, raw material cost increases; price-cost margin compression risk
- **Project timing risk**: Large project lumpiness in MCS and WSS could affect quarterly revenue and margin cadence
- **Regulatory delays**: Divestiture closing delayed by regulatory approval; future M&A may face similar hurdles
- **Competitive pressure in China**: Competitor actions contributing to ~1/3 of China decline
- **Margin execution risk**: H2 margin expansion relies on volume/mix normalization and cost actions; Applied Water mix normalization needed
- **Supply chain disruption**: Global supply chain disruptions could increase material costs beyond fixed-price contracts

### Key quotes

> “Coming off a strong 2025 with sustained momentum, 2026 is proving resilient with a solid first quarter financial performance despite a dynamic external environment.” — Matthew Pine

> “Demand remains solid with our ending backlog up sequentially to $4.7 billion, and our book-to-bill for the quarter was above 1.”

> “MCS will sequentially increase and exit the year post the international metrology divestiture, well in excess of 25% EBITDA margins.” — William Grogan

## Quarter one-liners

- **2026 Q1:** Xylem delivered solid Q1 2026 results with resilient demand, strong book-to-bill, $850M WSS outsourced water contract, maintained organic guidance, increased dividend, $581M buyback, and a $219M acquisition.
- **2025 Q4:** Xylem delivered record 2025 results and outlined 2026 guidance with 2-4% organic growth, 70-110 bps EBITDA margin expansion, but flagged a 2% top-line headwind from accelerated 80/20 simplification and China weakness. MCS project timing variability and tariff uncertainty remain key watch items. Mana
- **2025 Q3:** Xylem delivered strong Q3 with revenue growth across all segments, record EBITDA margin >23%, raised full-year guidance, and announced international metering divestiture; 80/20 simplification driving margins amid China headwinds and $180M tariff impact.','tone':{'mgmt':0.7,'mgmt_rationale':'Manageme
- **2025 Q2:** Xylem delivered strong Q2 with record 21.8% EBITDA margin, raised FY guidance, resilient demand, simplification driving margin expansion, tariff mitigation in place, acquired Vacom and Envirex for advanced treatment.','tone': {'mgmt': 0.7, 'mgmt_rationale': 'Prepared remarks emphasize record margins
- **2025 Q1:** Xylem delivered a strong Q1 with margin expansion and reaffirmed full‑year guidance, but flags tariff uncertainty and possible second‑half demand softness.
- **2024 Q4:** Xylem delivered record 2024 results with 6% revenue growth, 170bps EBITDA margin expansion, and double-digit EPS growth; 2025 guidance calls for 3-4% organic revenue growth and 70-120bps margin expansion despite 80/20 headwinds and tariff uncertainty.','tone': {'mgmt': 0.3, 'mgmt_rationale': 'Manage
- **2024 Q3:** Xylem posted record EBITDA margin and EPS in Q3, cited project timing delays in MCS and WSS, maintained full‑year guidance, and announced a majority‑stake acquisition of Idrica.
- **2024 Q2:** Xylem Q2 beat with 9% organic growth, 170bps margin expansion; raised FY guide on resilient demand, Evoqua synergies, 80/20 progress; MCS standout, Applied Water soft but improving.','tone': {'mgmt': 0.8, 'mgmt_rationale': 'Management highlighted strong outperformance across all metrics, raised full

## Theme arcs

- **EBITDA margin expansion** (improving): Margins rose from 21.2% to >23% as productivity and 80/20 simplification took effect
- **Demand resilience** (stable): Book‑to‑bill >1 and strong utility orders persisted despite macro headwinds
- **Project timing risk (MCS/WSS)** (deteriorating): Delays noted in Q3 2024, persisted through Q1 2026, though a record WSS contract was delivered
- **Tariff uncertainty** (new): First flagged in Q4 2024 and recurring each quarter as a potential cost and demand drag
- **China market weakness** (deteriorating): Order declines of ~30% appeared in Q1 2025 and remained a concern through Q1 2026
- **80/20 simplification** (new): Initially a margin driver, later a 2% top‑line headwind in 2025‑26
- **MCS mix pressure** (deteriorating): Energy‑water mix reduced MCS margins from Q1 2025 onward
- **Capital deployment (M&A, buybacks)** (improving): Multiple acquisitions, $1.5 bn buyback and higher dividend signal strong cash generation
- **Transformation initiatives** (improving): Operating‑model phases and self‑improvement programs stayed on track
- **Dividend and share‑repurchase policy** (improving): Dividend up ~8% and $581 m buyback executed in Q1 2026

## Guidance path

2024 Q2:vague → 2024 Q3:maintained → 2024 Q4:vague → 2025 Q1:maintained → 2025 Q2:vague → 2025 Q3:vague → 2025 Q4:maintained → 2026 Q1:maintained

---

Research context only. Not personalized investment advice.

API: `GET /bff/api/bigfive/earnings-intel/XYL`